OTC : TWAPF

Towa Pharmaceutical Co., Ltd. — Earnings Estimates

$26 USD

$0 (0.0%)

Volume
100
Average Volume
3
Market Capitalization
$1.28B
P/E Ratio
38.58
Dividend Yield
1.94%
Price Target
Year High
$26.00
Year Low
$16.83
Day High
Day Low
Payout Ratio
$0.75
Current Ratio
$2.76

Annual earnings financials

TWAPF financial data with annual/quarterly toggle

TWAPF GAAP EPS - Annual & Quarterly

TWAPF Sales Revenue - Annual & Quarterly

TWAPF Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

TWAPF Estimated and Actual Revenue by Quarter
TWAPF Estimated and Actual EPS by Quarter
TWAPF Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-03-31 1 14.88B 14.88B 14.88B 7.56B 7.56B 7.56B
2026-12-31 1 15.25B 15.25B 15.25B 7.75B 7.75B 7.75B
2026-09-30 1 13.65B 13.65B 13.65B 6.93B 6.93B 6.93B
2026-06-30 2 13.4B 13.46B 13.43B 6.81B 6.84B 6.82B
2026-03-31 3 14.01B 14.31B 14.2B 7.12B 7.27B 7.21B
2025-12-31 2 14.27B 14.39B 14.33B 7.25B 7.31B 7.28B
TWAPF Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-03-31 1 - - - 19.88B 19.88B 19.88B
2026-12-31 1 - - - 20.37B 20.37B 20.37B
2026-09-30 1 - - - 18.22B 18.22B 18.22B
2026-06-30 2 - - - 17.9B 17.98B 17.94B
2026-03-31 3 5.34B 5.34B 5.34B 18.71B 19.11B 18.96B
2025-12-31 2 3.62B 3.62B 3.62B 19.05B 19.21B 19.13B
TWAPF Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-03-31 1 78.52B 78.52B 78.52B 0 0 0 0
2026-12-31 1 80.45B 80.45B 80.45B 0 0 0 0
2026-09-30 1 71.99B 71.99B 71.99B 0 0 0 0
2026-06-30 2 70.7B 71.02B 70.86B 0 0 0 0
2026-03-31 3 73.9B 75.48B 74.92B 1 108.56911 108.56911 108.56911
2025-12-31 2 75.27B 75.89B 75.58B 1 73.62444 73.62444 73.62444